Bioaffinity Technologies, Inc.股价重挫36.97% 市值跌629.97万美元

自选股智能写手08-02

北京时间2024年08月02日21时34分，Bioaffinity Technologies, Inc.（BIAF.us）股票出现异动，股价快速下挫36.97%。截至发稿，该股报1.50美元/股，成交量44.1717万股，换手率3.89%，振幅4.20%。最近的财报数据显示，该股实现营业收入2.41百万美元，净利润-1.96百万美元，每股收益-0.20美元，毛利683313.00美元，市盈率-...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2456281956?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-08-02 21:34","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2456281956","market":"us","top_or_hot":-1,"title":"Bioaffinity Technologies, Inc.股价重挫36.97% 市值跌629.97万美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年08月02日21时34分，Bioaffinity Technologies, Inc.（BIAF.us）股票出现异动，股价快速下挫36.97%。截至发稿，该股报1.50美元/股，成交量44.1717万股，换手率3.89%，振幅4.20%。最近的财报数据显示，该股实现营业收入2.41百万美元，净利润-1.96百万美元，每股收益-0.20美元，毛利683313.00美元，市盈率-...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408022134009f0906a9&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bioaffinity Technologies, Inc.股价重挫36.97% 市值跌629.97万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioaffinity Technologies, Inc.股价重挫36.97% 市值跌629.97万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-02 21:34 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408022134009f0906a9&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年08月02日21时34分，Bioaffinity Technologies, Inc.（BIAF.us）股票出现异动，股价快速下挫36.97%。截至发稿，该股报1.50美元/股，成交量44.1717万股，换手率3.89%，振幅4.20%。最近的财报数据显示，该股实现营业收入2.41百万美元，净利润-1.96百万美元，每股收益-0.20美元，毛利683313.00美元，市盈率-...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408022134009f0906a9&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408022134009f0906a9&s=b","article_id":"2456281956","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408022134009f0906a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2456281956","pubTimestamp":1722605640,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年08月02日21时34分，Bioaffinity Technologies, Inc.股票出现异动，股价快速下挫36.97%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中，整体跌幅为1.28%。其相关个股中，Xwell, Inc.、徕博科、快而精医药涨幅较大，Bioaffinity Technologies, Inc.、Twist Bioscience Corporation、Applied Dna Sciences, Inc.较为活跃，换手率分别为3.91%、0.48%、0.30%，振幅较大的相关个股有Fulgent Genetics, Inc.、Caredx, Inc.、梅特勒-托利多，振幅分别为7.64%、5.34%、5.28%。Bioaffinity Technologies, Inc.公司简介：bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","BIAF":"bioAffinity Technologies, Inc."},"translate_title":"Bioaffinity Technologies, Inc. Stock Plunges 36.97%, Market Value Drops $6.2997 Million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BIAF":0.9},"content_text":"北京时间2024年08月02日21时34分，Bioaffinity Technologies, Inc.（BIAF.us）股票出现异动，股价快速下挫36.97%。截至发稿，该股报1.50美元/股，成交量44.1717万股，换手率3.89%，振幅4.20%。最近的财报数据显示，该股实现营业收入2.41百万美元，净利润-1.96百万美元，每股收益-0.20美元，毛利683313.00美元，市盈率-1.61倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Bioaffinity Technologies, Inc.股票所在的生命科学行业中，整体跌幅为1.28%。其相关个股中，Xwell, Inc.、徕博科、快而精医药涨幅较大，Bioaffinity Technologies, Inc.、Twist Bioscience Corporation、Applied Dna Sciences, Inc.较为活跃，换手率分别为3.91%、0.48%、0.30%，振幅较大的相关个股有Fulgent Genetics, Inc.、Caredx, Inc.、梅特勒-托利多，振幅分别为7.64%、5.34%、5.28%。Bioaffinity Technologies, Inc.公司简介：bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。公司使用能够优先靶向癌细胞和指示疾病状态的细胞群体的技术开发专有的无创诊断测试和癌症治疗药物。公司的产品CyPath Lung是一种用于检测早期肺癌的无创测试。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2456281956"}